Get started
Author

D.H. Gutteridge

Observed names: D H Gutteridge, D. Gutteridge, D. H. Gutteridge, DH Gutteridge, Gutteridge, D.H.
OpenAlex ID: A5018835156
Avascular necrosis of bone after high doses of dexamethasone during neurosurgery.
1982 · J McCluskey, D H Gutteridge · BMJ · 43
PDF
Slowing of Conduction in Visual Pathway in Hypothyroidism
1978 · F.L. Mastaglia, J.L. Black, et al. · The Lancet · 30
Fluoride in Osteoporosis - Vertebral, But Not Femoral Fracture Protection
1984 · D.H. Gutteridge, RI Price, et al. · Calcified Tissue International · 3
Abnormal thyroid stimulating hormone following pituitary surgery
1981 · G. K. Worth, R. W. Retallack, et al. · Journal of Endocrinological Investigation · 2
Intravenous pamidronate for Paget's disease — Optimal dosage for disease suppression
1992 · DH Gutteridge, GO Stewart, et al. · Bone and Mineral · 1
Intravenous pamidronate for Paget's disease — Optimal dosage for disease suppression
1992 · DH Gutteridge, GO Stewart, et al. · Bone and Mineral · 1
Long-Term Blood Pressure Variability and Cortical Thickness in Older Adults
2023 · D. Gutteridge, A. Segal, et al. · Heart Lung and Circulation
PDF
Bone Density Changes in Pamidronate Treatment of Paget's Disease: Enhanced Increase in the Nonpagetic Spine with Calcium plus Calcitroil Supplement
2001 · Price, R.I., Ward, L., et al. · UWA Profiles and Research Repository (UWA)
F021 Plasma lipids in combined continuous HRT-IUD levonorgestrel VS oral provera
1996 · BGA Stuckey, DH Gutteridge, et al. · Maturitas
P078 The prevalence and assessment of abnormal thyroid function tests in postmenopausal women not taking hormone replacement
1996 · TM Bozich, BGA Stuckey, et al. · Maturitas
Bone turnover marker response to treatment of Paget's disease with pamidronate
1995 · Randall, A.G., Kent, G.N., et al. · UWA Profiles and Research Repository (University of Western Australia)
Vitamin D receptor gene polymorphism is related to bone mineral density in postmenopausal osteoporotic, but not in young women
1995 · Steven Wilson, D.H. Gutteridge, et al. · UWA Profiles and Research Repository (UWA)
Regional bone density in severe Paget's disease following IV pamidronate: bone loss is prevented by calcitriol plus calcium
1995 · Lynley Ward, R.W. Retallack, et al. · UWA Profiles and Research Repository (UWA)
Bone density and fracture number are related to VDR alleles in postmenopausal osteoporotics
1995 · Steven Wilson, D.H. Gutteridge, et al. · UWA Profiles and Research Repository (University of Western Australia)
Intravenous Pamidronate in Paget's disease - quantification of remission and relapse, and implications for efficacious dosage
1994 · D.H. Gutteridge, B.G. Stuckey, et al. · UWA Profiles and Research Repository (UWA)
Rapid, Divergent Changes in Spinal and Forearm Bone Density following Short-Term Intravenous Treatment of Pagetʼs Disease with Pamidronate Disodium
1993 · R I Price, D H Gutteridge, et al. · The Endocrinologist
Pyridinium crosslink assays in monitoring treatment of Paget's disease of bone with Pamidronate
1993 · A.G. Randall, G.N. Kent, et al. · UWA Profiles and Research Repository (University of Western Australia)
Divergent Bone-Density Changes Following Treatment of Pagets-Disease with Intravenous Pamidronate Disodium
1992 · RI Price, D.H. Gutteridge, et al. · UWA Profiles and Research Repository (UWA)
Intravenous aminobisphosphonate (APD) in Paget's disease: Clinical, biochemical and histomorphometric responses
1990 · R. Price, A. Fenton, et al. · Bone and Mineral
Free 1,25 vitamin D index during a longitudinal study late pregnancy and lactation in women
1988 · Wilson, Scott; id_orcid 0000-0002-0357-1373, Retallack, R.W., et al. · UWA Profiles and Research Repository (UWA)
Periodontal diseases and smoking
1985 · D. H. Gutteridge · The Medical Journal of Australia
Written information for patients.
1979 · D H Gutteridge · BMJ
PDF
Works count: 22
Citation count: 80
H-index: 3
I10-index: 2
Year
Topic
Type